defibrillator devices global market press release

IQ4I Research & Consultancy Pvt. Ltd.

Defibrillator Devices Global Market

–Forecast to 2023

Defibrillator Devices Global Market estimated to be worth $17,710.8 million by 2023 IQ4I Research & Consultancy published a new report on “Defibrillator Devices Global

Market – Forecast To 2023” This report analyzes and studies the overall market, major

drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and

Rest of the World

IQ4I’s Report Contains 113 market data tables and 71 figures spread through 373

pages and an exhaustive TOC on “Defibrillator Devices Global Market [PRODUCTS

(Devices [Implantable (T-ICD {Single, Dual & Biventricular/CRT-D}, S-ICD), External

(AED, WED, ALS), Consumables and Servicing); APPLICATION (Ventricular

Tachycardia, Ventricular Fibrillation and Bradycardia); END-USERS (Hospitals, Pre-

hospital Care, Home Healthcare, Public Access Care, Ambulatory Surgical Centers

and Others); GEOGRAPHY (North America [U.S. & Others], Europe [Germany, France,

Italy & Others], Asia-Pacific [Japan, India, China & Others] and Rest of the World

[Brazil, Rest of Latin America and Middle East & Others)].

This report analyzes the Defibrillator devices global market in terms of market revenue ($

million) for all segments and it enables defibrillator devices stakeholders such as defibrillator

device manufacturers, defibrillator device distributors and wholesalers, OEM (Original

Equipment Manufacturers)/contract manufacturers, clinics and hospitals, various research

and consulting firms, group purchasing organizations (GPOs) and healthcare Industries to

identify and analyze market expansion opportunities, upcoming technologies and

competition in Defibrillator devices global market.

Heart a major organ of human body plays an important role in maintaining the normal

metabolism of the body by pumping the blood throughout the body via the circulatory

system, supplying oxygen and nutrients to the tissues and removing carbon-di-oxide and

others wastes. Inorder to carry out these functions, systematic heart rhythms plays a major

role and if these rhythms fail then overall function of the body organs becomes abnormal

resulting in sudden cardiac arrest and death. Hence when patient suffers from irregular

heartbeats a life saving device called defibrillator should be used for delivering shocks to

heart muscles to regain the normal heart beats. These defibrillator devices are mainly used

as therapeutic tools to save the life of a patient immediately after the attack and enhance

their safety.



–Forecast to 2023

According to IQ4I analysis, the defibrillator devices global market is expected to grow at mid

to high single digit CAGR to reach $17,710.8 million by 2023. Increase in aging population

and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators

in public access areas and favorable reimbursement policies are some of the factors driving

the defibrillator devices market growth. Emergence of next generation integrated ICD’s,

market expansion opportunities in emerging countries and increasing trend for MRI

compatible defibrillators are few opportunities for the defibrillator devices market. However,

patient safety risks due to chances of infections and other complications while using

defibrillators and lack of awareness on sudden cardiac arrests are expected to hamper the

market growth.

The defibrillator devices global market is mainly segmented by products, applications, end-

users and by geography. The defibrillator devices global market by the products is

segmented into devices, by consumables and servicing. The devices segment accounted for

the largest share in 2016. Among these devices market is further classified into implantable

cardioverter defibrillators and external defibrillators. Implantable cardioverter defibrillators

hold the major share in 2016.

Based on application, the market is segmented into ventricular tachycardia, ventricular

fibrillation and bradycardia. The ventricular tachycardia segment accounted for the largest

share in 2016 due to rise in aging population and increasing incidences of cardiovascular

diseases.

End-Users are further segmented into hospitals, home healthcare, pre-hospital care, public

access care, ambulatory surgical centers and others. Among the end users of the

defibrillator devices market home healthcare is expected to grow at a strong CAGR of XX%

due to availability of wide range of ICD’s, which enhances patient safety thus driving the

market growth rate.

Advancements in technology includes customized defibrillator devices & consumables,

leadless defibrillators, 3D printed multifunctional integumentary membrane devices for

arrhythmias diagnosis, ambulance drone and ambulance robotic assisted AED’s. One of the

most advantageous advancement in this market includes next generation ICD’s, which have

emerged as an useful tool in defibrillator device industry due to its integration with bi-

functional capabilities that which plays a role of performing both as a pacemaker and

defibrillator for providing effective treatment in patients with both ventricular tachycardia and

fibrillation conditions. It has improved capacitor, detection algorithms, lead systems, battery



–Forecast to 2023

longevity and advanced sophisticated sensor functions for reducing inappropriate shocks.

These are programmable and can be implanted within a small incision of about 2 to 2.5 inch

for providing improved detection, therapy and stored diagnostic information about arrhythmia

through wireless technology. For instance, Boston Scientific Inc (U.S.) provides Dynagen X4

and Inogen X4 CRT-Ds products with quadripolar leads with 70 percent more pacing

options, high capture thresholds and large battery capacity compared to conventional ICD’s.

Matured regions such as North America commanded the largest market share in 2016 due

to high investments in healthcare infrastructures, availability of government funds improved

market growth in this region. However, Asia-pacific region is expected to grow at the highest

CAGR from 2016-2023 due to increased healthcare awareness, improved economic growth,

and increasing awareness among the people about sudden cardiac arrest and death.

Significant launch of new products, agreement, partnership, collaborations, and joint

ventures are the industry trends that are playing a major role in the market growth.

Market is highly consolidated, key players like Medtronic PLC (Ireland), Asahi Kasei

Corporation (Zoll Medical Corporation) (Japan), Boston Scientific Corporation (U.S.), Abbott

Laboratories (St. Jude Medical’s) (U.S.), Biotronik (Germany) holds a major share in

defibrillator devices market.

Major players in defibrillator devices global market include Boston Scientific Corporation

(U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Philips Healthcare

(Netherlands), Asahi Kasei Corporation (Japan), Biotronik Se & Co. Kg (Germany), Stryker

Corporation (U.S.), LivaNova (U.K.) and Nihon Kohden Corporation (Japan).



–Forecast to 2023

Reasons for buying this report:

Identification and analysis of the defibrillator devices market segments by

applications, products, mode of operation, end-users and geography

Analysis of the global market by identifying various sub-segments of the defibrillator

devices

Analysis of Defibrillator devices global market by number of units and their average

selling prices

Revenue forecast of the defibrillator devices market and strategic analysis of each

submarket with respect to individual growth trends

Revenue forecast of the defibrillator devices market with respect to North America,

Europe, Asia-Pacific, Rest of the World (RoW) and their countries

Identification of the major market trends and factors driving or inhibiting the growth of

the defibrillator devices global and its various sub-markets

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market

Analysis of the market share & individual products market share for AED’s, ICD’s,

ALS, porters five force model, patent filing trends and technological advancements of

the defibrillator devices market

Analysis of the regulatory bodies guiding the manufacturers, reimbursement

scenario, supply chain and shares of external & internal devices of the defibrillator

devices market

Analysis of key players in Defibrillator devices global market and product category

details of their product offerings, revenues, business strategies and SWOTs

Established and Emerging players (54) and their product offerings.



–Forecast to 2023

FIGURE 1

DEFIBRILLATOR DEVICES GLOBAL MARKET SEGMENTATION


Hospitals

Pre-hospital Care

Public Access Care

Home Healthcare

Ambulatory Surgical Centers

Others

By End-Users

Devices Consumables

Servicing

By Product

Ventricular Tachycardia

Ventricular Fibrillation

BradycardiaArrhythmia

By Application

ICD

T-ICD’s

S-ICD’s

External

AED’s

ALS

WCD

defibrillator devices global market press release

Health & Medicine